Corebridge Financial »

Halozyme Therapeutics shares owned by Corebridge Financial

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Corebridge Financial from 13F filings

Historical chart of Corebridge Financial investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Corebridge Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Corebridge Financial

Quarter filed Position value Share count Share price at filing
2025-03-31 $13M 201k 63.81
2024-12-31 $9.8M 205k 47.81